drugset / Trial / NCT05889455
Effect of Sildenafil in Individuals With Migraine Pretreated With Erenumab
RandomizedCrossoverQuadruple-blindOther
Summary
An outstanding scientific question, that merits further investigation, is whether dilation of intracranial arteries is implicated in the pathogenesis of cephalic pain in migraine. Here, we hypothesize that experimentally-induced dilation of intracranial arteries using intake of sildenafil (a potent vasodilator) can induce cephalic pain with migraine-like features in people with migraine, who prior to the infusion are administered erenumab (anti-calcitonin gene-related peptide (CGRP) receptor monoclonal antibody.
Timeline
- Start
- 2023-04-20
- Primary completion
- 2023-10-12
- Completion
- 2023-10-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | 100 mg | Oral |